UPC CFI 776/2025
Aug 22, 2025·EP3769722 Unitary patent · LOW PROFILE DELIVERY SYSTEM FOR TRANSCATHETER HEART VALVE
- Case details
- StatusCase Closed (Withdrawn)ActionGenericCategoryGeneric
- Parties
- Claimants
- Meril Life Sciences Pvt Ltd.Operating co.
Representatives- Roman Hans-Werner Wuertenberger-Hogan Lovells International LLP
- Andreas von Falck-Hogan Lovells International LLP
- Alexander Klicznik-Hogan Lovells International LLP
- Karin Westerberg-Sandart & Partners Advokatbyrå
- Julia Ericsson-Sandart & Partners Advokatbyrå
- Kerstin Jonen-Hogan Lovells International LLP
- Lars-Fabian Blume-Hogan Lovells International LLP
- Beatrice Wilden-Hogan Lovells International LLP
- Friederike Hermes-Hogan Lovells International LLP
Respondents- Edwards Lifesciences CorporationOperating co.
Representatives- Jens Olsson-Gulliksson
- Siddharth Kusumakar-Powell Gilbert (Europe) LLP
- Bryce Matthewson-Powell Gilbert (Europe) LLP
- Adam Rimmer-Powell Gilbert (Europe) LLP
- Jonas Weickert-Thum & Partner
- Bernhard Thum-Thum & Partner
- Division
- Nordic-Baltic RD
- Technology
- InstrumentsMedical technology
- Language
- English
- First decided
- Dec 5, 2025
- Last decision
- May 12, 2026
- EPO Opposition
- J A Kemp LLPAdmissible2024-03-07
| Median days to first decision | |
|---|---|
| All UPC | 124 |
| Nordic-Baltic RD | Locked |
| Judge Stefan Johansson | Locked |
| Judge Mélanie Bessaud | Locked |
| Judge Kai Härmand | Locked |
| Judge Stefan Wilhelm | Locked |
At the UPC: Meril Group (60 cases)·Edwards Lifesciences Group (57 cases)
This dispute contains 7 other proceedings
UPC CFI 775/2025·UPC CFI 777/2025·CC 14226/2024·UPC CFI 380/2023·UPC APP 14061/2024 and 2 more
Start a free trial to see how each one ended.
More cases: Nordic-Baltic RD·2025
- 2026-05-12
Summary: The parties reached a settlement and withdrew their respective applications for cost decisions (CFI_775/2025, CFI_776/2025, and CFI_777/2025). The Court permitted the withdrawals, declared the proceedings closed, and granted confidentiality orders under Art. 58 UPCA restricting access to designated confidential information in the cost decision applications.
Show the legal issues (3)
- Withdrawal of cost decision applications following settlement
- Confidentiality orders under Art. 58 UPCA
- Restriction of access to confidential information under Rule 262A RoP
- 2025-12-05Application RoP262APublic
Summary: The Nordic-Baltic Regional Division stayed the cost proceedings between Edwards Lifesciences and Meril pending the outcome of EPO Board of Appeal opposition proceedings against EP 3 769 722, and provisionally ordered confidentiality obligations by mutual agreement of the parties.
Show the legal issues (3)
- R. 295(d) RoP stay of proceedings at joint request
- Stay pending EPO Board of Appeal opposition outcome
- R. 262/262A RoP provisional confidentiality of sensitive information
| Document title | Date | Public |
|---|---|---|
| Case closed | 2026-05-12 | Not public |
| Decision | 2026-05-12 | Not public |
| Decision | 2026-05-12 | Public |
| Receipt | 2026-03-26 | Not public |
| Cover sheet | 2026-03-26 | Not public |
| Application document Defendant | 2026-03-26 | Not public |
| Receipt | 2026-03-26 | Not public |
| Cover sheet | 2026-03-26 | Not public |
| Submission Defendant/Respondent | 2026-03-26 | Not public |
| Order | 2026-03-23 | Not public |